The pan-cancer landscape of aldo-keto reductase1B10 reveals that its expression is diminished in gastric cancer
These data indicates that AKR1B10 may be an important factor in the development and progression and a potential therapeutic target for multiple cancers, but plays as a protector in the gastric tissues.
Authors
- Deliang Cao
- Jaume Farrés (ORCID: https://orcid.org/0000-0001-9069-3987)
- Meng Gao (ORCID: https://orcid.org/0000-0001-6941-0284)
- Juan Boo Liang (ORCID: https://orcid.org/0000-0001-6024-0856)
- Anqi Wu (ORCID: https://orcid.org/0000-0002-7483-7618)
- Guoqing Li (ORCID: https://orcid.org/0000-0001-5274-275X)
- Jiaqi Huang (ORCID: https://orcid.org/0000-0002-6514-3075)
- Hao Li (ORCID: https://orcid.org/0000-0003-0050-9029)
Institutions
- Universitat Autònoma de Barcelona (ES)
- University of South China (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2024-12-06
- DOI
- https://doi.org/10.3389/fimmu.2024.1488042
- Citations
- 1
- Primary Topic
- Aldose Reductase and Taurine
- Type
- article
- Field-Weighted Citation Impact
- 0.33